Source: Benzinga

InterMune Was acquired by Legacy Pharma Inc. for undisclosed amounted

Read full article »

InterMune's Competitors | InterMune's News | InterMune's Financials

Followers on Owler

101

Est. Annual Revenue

$100-500M

Est. Employees

250-500

CEO

Update CEO

CEO Approval Rating

- -/100

InterMune engages in the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases.